Novo Nordisk, a Danish multinational pharmaceutical company, was working towards streamlining their processes of getting new drugs on the market. Their long-term goal is to reduce the time this takes from approximately nine months to four days. Our team at Amsterdam Data Collective (previously DAMVAD Analytics) helped them move towards their goal by developing a system of digital patients. These simulate patients’ paths through clinical trials. They are now working with a new, user-friendly application that they can further expand on in the future.